David U. Himmelberger

BS ’69, Mathematics, Millersville University
MS ’72, Statistics, Purdue University

"I chose to apply my statistical training to medicine and healthcare because I believe this is a valuable endeavor that helps provide patients, caregivers, researchers, and policy makers with useful tools for making objective and transparent decisions."

Since 1987, David U. Himmelberger has served as the CEO and managing director of Health Outcomes Group, an international medical consulting group specializing in patient reported outcomes, quality of life, and economic evaluation. Before founding Health Outcomes Group, he worked at Syntex Corporation as director of Worldwide Market Research and Strategic Planning. He began his career as a biostatistician at Stanford University Medical School.

With 40 years of experience in the healthcare industry, Himmelberger has developed five quality of life questionnaires used in clinical trials. He also has managed and led the evaluation of a nationwide survey of 80,000 healthcare professionals. He has contributed to the studies of quality of life, smoking, arthritis, and competitive athletics.

CAREER HIGHLIGHTS:

• 1987-Present: CEO and founder of Health Outcomes Group, a leader in outcomes evaluations in healthcare
• 2001 - Established standards for patient outcomes evaluations in multinational clinical trials
• 1972-1985 - Biostatistician, Stanford University Medical School
• 1978 - Established link between cigarette smoking and congenital abnormalities